Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
89 studies found for:    Carcinoembryonic antigen
Show Display Options
Rank Status Study
21 Recruiting A Study of RO6958688 in Patients With Locally Advanced and/or Metastatic Solid Tumors
Condition: Solid Cancers
Intervention: Drug: RO6958688
22 Recruiting A Study of Intravenous RO6895882 and MPDL3280A Combination in Patients With Locally Advanced and/or Metastatic Solid Tumors
Condition: Solid Cancers
Interventions: Drug: MPDL3280A [TECENTRIQ];   Drug: RO6895882
23 Completed Vaccine Therapy in Treating Patients With Refractory Stage IV Cancer
Condition: Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: CEA peptide 1-6D
24 Completed Intensive Versus Minimal Surveillance of Patients With Resected Dukes B2-C Colorectal Carcinoma
Conditions: Colorectal Cancer;   Surveillance
Intervention: Other: surveillance program after completion of primary treatment
25 Completed
Has Results
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Docetaxel;   Biological: PANVAC-V;   Biological: PANVAC-F;   Biological: Sargramostim
26 Recruiting Tumor Relapsed Study of Serum Trxr Activity in Advanced Non-small Cell Lung Cancer
Conditions: Advanced Non-small Cell Lung Cancer;   First Line Treatment;   Thioredoxin Reductase Activity;   Carcinoembryonic Antigen;   Progression
Intervention:
27 Active, not recruiting Prophylactic Cranial Irradiation in Patients With Lung Adenocarcinoma With High Risk of Brain Metastasis
Condition: Lung Cancer
Intervention: Radiation: Prophylactic Cranial Irradiation
28 Completed Radiation Therapy Before Surgery Compared With Chemotherapy Plus Radiation After Surgery in Treating Patients With Rectal Cancer That Can Be Surgically Removed
Condition: Colorectal Cancer
Interventions: Drug: fluorouracil;   Drug: leucovorin calcium;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy;   Radiation: radiation therapy
29 Completed A Study to Evaluate the Safety and Tolerability of MEDI-565 in Adults With Gastrointestinal Adenocarcinomas
Condition: Gastrointestinal Adenocarcinomas
Intervention: Drug: MEDI-565
30 Completed Immune Response in Peripheral Blood of Patients With Colon Cancer
Condition: Colorectal Cancer
Interventions: Other: immunoenzyme technique;   Other: laboratory biomarker analysis
31 Completed
Has Results
Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma
Condition: Pancreatic Adenocarcinoma
Interventions: Biological: modified CEA peptide (10mcg);   Biological: modified CEA peptide (100mcg);   Biological: modified CEA peptide (1000mcg)
32 Recruiting Serum and Peritoneal CEA and CA 19-9 for Gastric Adenocarcinoma
Condition: Gastric Adenocarcinoma
Interventions: Procedure: gastrectomy;   Procedure: sampling of peritoneal washing aspirate
33 Completed Study of Circulating Markers in Serum of Patients Treated for Metastatic Colorectal Cancer
Condition: Metastatic Colorectal Cancer
Intervention: Other: Blood sampling
34 Recruiting Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas
Condition: Carcinoma, Pancreatic Ductal
Intervention: Other: samples of blood, saliva and urine
35 Completed Dendritic Cell Vaccination in Patients With Advanced Colorectal Cancer
Condition: Colorectal Neoplasms
Intervention: Biological: MelCancerVac
36 Recruiting 89Zr-AMG211 PET Imaging Study
Condition: Advanced Gastrointestinal Cancer
Interventions: Drug: 89Zr-AMG211;   Device: 89-ZrAMG211 PET
37 Completed Denileukin Diftitox Followed by Vaccine Therapy in Treating Patients With Metastatic Cancer
Conditions: Breast Cancer;   Colorectal Cancer;   Lung Cancer;   Pancreatic Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Biological: denileukin diftitox;   Biological: recombinant fowlpox-CEA(6D)/TRICOM vaccine;   Biological: therapeutic autologous dendritic cells
38 Completed New Chemotherapy Regimen in the Treatment of Advanced Gallbladder Carcinoma
Condition: Gallbladder Neoplasms
Interventions: Drug: Somatostatin;   Drug: epirubicin, cisplatin, LV(Leucovorin)、 5-FU(5-Fluorouracil)
39 Recruiting Correlation Between Circulating Tumour Markers Early Variations and Clinical Response in First Line Treatment of Metastatic Colorectal Cancer
Conditions: Circulating Markers;   Metastatic Colorectal Cancer
Intervention: Procedure: Blood sampling for free mutant DNA analysis
40 Recruiting Liver Resection Versus Radio-chemotherapy-Transplantation for Hilar Cholangiocarcinoma
Conditions: Cholangiocarcinoma;   Morphological Diagnosis of Hilar Cholangiocarcinoma (Excluded Type 1), Resectable With Expected R0 Margins on an intent-to Treat Basis.
Interventions: Procedure: CAPECITABINE-Radiotherapy -Liver Transplantation;   Procedure: RESECTION

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.